CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Asthenozoospermia

A condition in which the percentage of motile sperm is abnormally low.

Drugs by status

Phase 3 trials (6)

  • vitamin e
  • folic acid
  • myoinositol
  • walnut
  • multivitamins
  • omega-3 fatty acids

Phase 2 trials (1)

  • zinc dichloride

Phase 1 trials (2)

  • Linggui
  • stsp-0902

Other trials (5)

  • ginseng
  • pentoxifylline
  • ramipril
  • ubiquinone
  • royal jelly

Organizations

Organization Involved with Phase 3 Indications (5)

  • National Nutrition and Food Technology Institute
  • AGUNCO Obstetrics and Gynecology Centre
  • Cedars-Sinai Medical Center
  • University of California, Los Angeles
  • University of Catania

Organization Involved with Phase 2 Indications (3)

  • Baylor University
  • Babylon University
  • Government of Iraq

Organization Involved with Other Experimental Indications (6)

  • Severance Hospital
  • Cornell University
  • Gonabad University of Medical Sciences
  • Mashhad University of Medical Sciences
  • Yonsei University
  • Ilwha Co.,Ltd.

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.